Viva Biotech attaches great importance to protecting client information and intellectual property:
--We continuously optimize the quality management system.
--We always uphold the business ethics of honesty and trustworthiness, legal compliance and integrity, and we strictly comply with laws and regulations related to corporate governance and the Corporate Governance Code.
--We actively communicate with stakeholders and strictly comply with the environmental management systems.
--We safeguard employees' occupational health and promote professional development.
The Group attaches great importance to protection of customer information and trade secrets. In strict compliance with the relevant regulations on information security and privacy protection, the Group has established an information security team and a strict information management system to standardize the Regulations on Confidentiality of Customer Information, define the scope of confidential information of the Group and departments and methods for keeping confidentiality, and formulate methods for dealing with information leaks. In terms of computer information security management, the Group acts in strict accordance with laws and regulations and formulated the Standards for Computer Information Security Management, Computer Management System and other systems to ensure the stable operation of the Group’s network and the security of information and materials.
Intellectual property rights constantly empower Viva Biotech's innovation and development. To better protect the intellectual property rights and patents of clients and the Group in R&D projects, Viva Biotech formulated and firmly implemented the Intellectual Property Rights Protection Measures, strictly following the Patent Law of the People's Republic of China and the Trademark Law of the People's Republic of China. Before the commencement of a project, we enter into a confidentiality agreement with the client, encrypt the relevant documents and reports, and transmit them through the encrypted network disk. Concerning the intellectual property risks among projects, the Group will evaluate the intellectual property rights of the projects for which clients intend to carry out R&D within the Group during the project negotiation stage to ensure that there is no conflict of intellectual property rights.
Viva Biotech has always paid close attention to effective service quality improvement. It is committed to providing world-leading drug discovery services and developing high-quality, safe drugs that cater to clients' needs. The Group strictly abides by relevant laws and regulations, such as the Product Quality Law of the People's Republic of China and the Safety Production Law of the People's Republic of China. It has obtained ISO 9001:2015 quality management system certification, continuously upholding the quality control system. The Company regularly reviews, sorts out, and revises internal regulatory documents and constantly updates quality control standards on risk control, monitoring and measurement control, internal audit, and error correction. We have also strengthened the quality concept through staff training and technology R&D and continuously promoted improving the quality management level.
Viva Biotech upholds the business ethics of honesty and trustworthiness, legal compliance, integrity, and self-discipline, acts in strict accordance with relevant laws and regulations on corporate governance and the Corporate Governance Code, and demonstrates zero-tolerance for bribery, extortion, fraud, and money laundering. The Group follows the Criminal Law of the People's Republic of China, the Anti-Unfair Competition Law of the People's Republic of China, and other relevant laws and regulations. We established an anti-fraud group and formulated the Anti-Money Laundering Management System and Anti-Fraud Work Regulations, which specified prohibited acts and corresponding penalties to promote systematic anti-corruption management.
The Group has set up a telephone hotline, e-mail, and other reporting channels concerning professional ethics issues and fraud cases. Through these, employees at all levels and stakeholders with direct or indirect economic relations with the Group can submit and report cases or suspected cases of violation of professional ethics or fraud by employees of the Group.
Viva Biotech regards stakeholders as indispensable partners for its long-term development. We attach great importance to stakeholders' opinions, listen to their voices via smooth communication channels, and actively respond to issues of concern.
Viva Biotech has formulated the Environmental Protection Management Rules to define the environmental protection responsibilities and specific management measures for each department. We also carry out annual emission tests to effectively control the discharge of wastewater, waste gas, solid wastes ("the three wastes"), and sundries generated in the production and operation of the Group. Meanwhile, we strictly follow the environmental protection's "Three Simultaneities" requirements to ensure that pollution prevention and control facilities of construction projects are designed, constructed, and put into use according to guidelines.
Regarding employees' rights and interests, the Group has created a fair and smooth talent selection and appointment mechanism for employees. We strictly comply with the Labor Law of the People's Republic of China and other relevant laws and regulations. In terms of employees’ health and safety, the Group strictly complies with the Law of the People's Republic of China on Work Safety and other relevant laws and regulations. We clearly state the safety responsibilities of employees to protect their occupational health and safety. In terms of training, the Group standardizes management and provides diversified training for employees, including new employee orientation, safety training, chemical R&D and biological R&D training, and more to improve the professional skills of employees.